110 related articles for article (PubMed ID: 27659777)
1. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
Casabonne D; Benavente Y; Seifert J; Costas L; Armesto M; Arestin M; Besson C; Hosnijeh FS; Duell EJ; Weiderpass E; Masala G; Kaaks R; Canzian F; Chirlaque MD; Perduca V; Mancini FR; Pala V; Trichopoulou A; Karakatsani A; La Vecchia C; Sánchez MJ; Tumino R; Gunter MJ; Amiano P; Panico S; Sacerdote C; Schmidt JA; Boeing H; Schulze MB; Barricarte A; Riboli E; Olsen A; Tjønneland A; Vermeulen R; Nieters A; Lawrie CH; de Sanjosé S
Int J Cancer; 2020 Sep; 147(5):1315-1324. PubMed ID: 32012253
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case-control study.
Davari N; Ahmadpour F; Kiani AA; Azadpour M; Asadi ZT
BMC Res Notes; 2021 Jan; 14(1):21. PubMed ID: 33430952
[TBL] [Abstract][Full Text] [Related]
5. miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia.
Hadi N; Namazi F; Ketabchi F; Khosravian F; Nateghi B; Talebi A; Baghi M; Mianesaz H; Zare F; Salehi M
Pathol Res Pract; 2022 Oct; 238():154077. PubMed ID: 36037658
[TBL] [Abstract][Full Text] [Related]
6. Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients.
Farzadfard E; Kalantari T; Tamaddon G
J Blood Med; 2020; 11():97-102. PubMed ID: 32210655
[TBL] [Abstract][Full Text] [Related]
7. An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.
Alharthi A; Beck D; Howard DR; Hillmen P; Oates M; Pettitt A; Wagner SD
BMC Res Notes; 2018 May; 11(1):280. PubMed ID: 29739419
[TBL] [Abstract][Full Text] [Related]
8. miR-155 as a Biomarker in B-Cell Malignancies.
Due H; Svendsen P; Bødker JS; Schmitz A; Bøgsted M; Johnsen HE; El-Galaly TC; Roug AS; Dybkær K
Biomed Res Int; 2016; 2016():9513037. PubMed ID: 27294145
[TBL] [Abstract][Full Text] [Related]
9. Combined Delivery of miR-15/16 through Humanized Ferritin Nanocages for the Treatment of Chronic Lymphocytic Leukemia.
Liberati FR; Di Russo S; Barolo L; Peruzzi G; Farina MV; Spizzichino S; Di Fonzo F; Quaglio D; Pisano L; Botta B; Giorgi A; Boffi A; Cutruzzolà F; Paone A; Baiocco P
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543296
[TBL] [Abstract][Full Text] [Related]
10. Targetome Analysis Revealed Involvement of MiR-126 in Neurotrophin Signaling Pathway: A Possible Role in Prevention of Glioma Development.
Rouigari M; Dehbashi M; Ghaedi K; Pourhossein M
Cell J; 2018 Jul; 20(2):150-156. PubMed ID: 29633591
[TBL] [Abstract][Full Text] [Related]
11. miRNA Biology in Chronic Lymphocytic Leukemia.
Bayraktar R; Fontana B; Calin GA; Nemeth K
Semin Hematol; 2024 Mar; ():. PubMed ID: 38724414
[TBL] [Abstract][Full Text] [Related]
12. The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
Mozessohn L; Earle C; Spaner D; Cheng SY; Kumar M; Buckstein R
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754925
[TBL] [Abstract][Full Text] [Related]
13. Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial.
Robak T; Warzocha K; Govind Babu K; Kulyaba Y; Kuliczkowski K; Abdulkadyrov K; Loscertales J; Kryachok I; Kłoczko J; Rekhtman G; Homenda W; Błoński JZ; McKeown A; Gorczyca MM; Carey JL; Chang CN; Lisby S; Gupta IV; Grosicki S
Leuk Lymphoma; 2017 May; 58(5):1084-1093. PubMed ID: 27731748
[TBL] [Abstract][Full Text] [Related]
14. Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.
Filip AA; Grenda A; Popek S; Koczkodaj D; Michalak-Wojnowska M; Budzyński M; Wąsik-Szczepanek E; Zmorzyński S; Karczmarczyk A; Giannopoulos K
Ann Hematol; 2017 Jan; 96(1):33-50. PubMed ID: 27730344
[TBL] [Abstract][Full Text] [Related]
15. TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.
Minervini CF; Cumbo C; Orsini P; Brunetti C; Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Impera L; Giordano A; Specchia G; Albano F
Diagn Pathol; 2016 Oct; 11(1):96. PubMed ID: 27724982
[TBL] [Abstract][Full Text] [Related]
16. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
[TBL] [Abstract][Full Text] [Related]
17. Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics.
Matondo M; Marcellin M; Chaoui K; Bousquet-Dubouch MP; Gonzalez-de-Peredo A; Monsarrat B; Burlet-Schiltz O
Proteomics; 2017 Apr; 17(7):. PubMed ID: 27709814
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
[TBL] [Abstract][Full Text] [Related]
19. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.
Galletti G; Caligaris-Cappio F; Bertilaccio MT
Leukemia; 2016 Dec; 30(12):2293-2301. PubMed ID: 27677742
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
